1427 Evaluating MHC-II antigen presentation in vivo to identify targets for immunotherapy

1427 Evaluating MHC-II antigen presentation in vivo to identify targets for immunotherapy

Bibliographic Details
Main Authors:	Bin Fang, John Koomen, Paul Stewart, Alex M Jaeger, William Rideout, Tyler Jacks, Andrew Weeden, Anika Ali, Victoria Izumi, Emma Sanders
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

MHC-II neoantigens shape tumour immunity and response to immunotherapy
by: Luoma, Adrienne M., et al.
Published: (2020)

Goizueta 1427ko apeoan
by: Patziku Perurena
Published: (2008-08-01)

The Political History of the Golden Horde in 1419–1427
by: Parunin A.V.
Published: (2019-09-01)

Writing the Orient: Johannes Schiltberger's Reisebuch (1394–1427)
by: Wolpert, F
Published: (2016)

14.27 Economics and E-commerce, Fall 2000
by: Ellison, Glenn
Published: (2000)

Rynek nieruchomości w Starej Warszawie w latach 1427–1453
by: Piotr Łozowski
Published: (2017-05-01)

Capítulos entre Murcia y Orihuela: relaciones de frontera (1427)
by: Clara Alarcón Ruiz, et al.
Published: (1997-12-01)

The Avian MHC-Antigen System
by: Diana Wesselinova
Published: (2002-10-01)

Antigen presentation by MHC-dressed cells
by: Masafumi eNakayama
Published: (2015-01-01)

Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.
by: Mimura, Y, et al.
Published: (2007)

MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy
by: Renato B. Baleeiro, et al.
Published: (2022-12-01)

MHC antigens and cancer: implications for T-cell surveillance.
by: Browning, M, et al.
Published: (1992)

MECHANISM OF MHC-MEDIATED ANTIGEN RECOGNITION BY T-CELLS
by: Bowness, P, et al.
Published: (1993)

The human T lymphocyte receptor complex for antigen and MHC.
by: Royer, H, et al.
Published: (1985)

The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
by: Richard J O'Reilly, et al.
Published: (2023-09-01)

Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
by: Storni, T, et al.
Published: (2004)

Monoclonal antibodies to rat leukocyte surface antigens, MHC antigens, and immunoglobulins.
by: Puklavec, M, et al.
Published: (2001)

Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma
by: Elena Shklovskaya, et al.
Published: (2020-11-01)

MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
by: Kayla R Wilson, et al.
Published: (2018-01-01)

P1427: RARE ANAEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP): DISTRIBUTION OF PATIENTS AFFECTED BY RADS IN EUROPE
by: José Martín Solórzano González, et al.
Published: (2023-08-01)

A comparison of complementary and alternative medicine users and use across geographical areas: A national survey of 1,427 women
by: Sibbritt David, et al.
Published: (2011-10-01)

Identification of antigens presented by MHC for vaccines against tuberculosis
by: Bettencourt, P, et al.
Published: (2020)

MHC-peptide tetramers for the analysis of antigen-specific T cells.
by: Sims, S, et al.
Published: (2010)

Identification of antigens presented by MHC for vaccines against tuberculosis
by: Bettencourt, P, et al.
Published: (2020)

MHC structure and function – antigen presentation. Part 1
by: Anna Carla Goldberg, et al.

Casa, corte y cancillería del obispo de Valencia Hug de Llupià (1398-1427)
by: María Milagros Cárcel Ortí
Published: (1998-12-01)

An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity
by: Marcela V Maus, et al.
Published: (2016-01-01)

In vivo virulence of MHC-adapted AIDS virus serially-passaged through MHC-mismatched hosts.
by: Sayuri Seki, et al.
Published: (2017-09-01)

NetCleave: an open-source algorithm for predicting C-terminal antigen processing for MHC-I and MHC-II
by: Pep Amengual-Rigo, et al.
Published: (2021-06-01)

Le catasto florentin de 1427-1430 : présentation générale de l'enquête et du code
by: Christiane Klapisch-Zuber, et al.
Published: (2016-11-01)

La introducción de la insaculación en la Corona de Aragón: Xàtiva, 1427. Transcripción documental
by: Juan Antonio Barrio Barrio
Published: (1991-12-01)

Targeted acidosis mediated delivery of antigenic MHC-binding peptides
by: Joey J. Kelly, et al.
Published: (2024-04-01)

Suppression of Non-Random Fertilization by MHC Class I Antigens
by: Junki Kamiya, et al.
Published: (2020-11-01)

MHC Class II Auto-antigen Processing and Presentation is Unconventional
by: Scheherazade eSadegh-Nasseri, et al.
Published: (2015-07-01)

Antigen processing for MHC class II presentation via autophagy
by: Christian eMunz
Published: (2012-02-01)

MHC-I genotype and tumor mutational burden predict response to immunotherapy
by: Aaron M. Goodman, et al.
Published: (2020-05-01)

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
by: Irene Romero, et al.
Published: (2018-01-01)

Immunotherapy of tumors with α2-macroglobulin-antigen complexes pre-formed in vivo.
by: Sudesh Pawaria, et al.
Published: (2012-01-01)

Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.
by: Christopher C Kemball, et al.
Published: (2009-10-01)

Antigen-specific T cell activation independently of the MHC: chimeric antigen receptor (CAR)-redirected T cells.
by: Hinrich eAbken, et al.
Published: (2013-11-01)